Comparison of the reinforcing effects of cocaine and cocaine/heroin combinations under progressive ratio and choice schedules in rats

Neuropsychopharmacology

Volumn 30, Issue 2, 2005, Pages 286-295

  Ward, Sara Jane ^a   Morgan, Drake ^a   Roberts, David C S ^a,b  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b Dept of Physiology and Pharmacology ^*  (United States)

Author keywords

Concurrent schedules; Preference; Reinforcing efficacy; Schedules of reinforcement; Self administration; Speedball

Indexed keywords

COCAINE; DIAMORPHINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; CANNULA; COCAINE DEPENDENCE; CONTROLLED STUDY; DECISION MAKING; DOSE RESPONSE; DOUBLE LUMEN TUBE; DRUG EFFECT; DRUG MECHANISM; DRUG SELF ADMINISTRATION; HEROIN DEPENDENCE; INSTRUMENTAL CONDITIONING; MALE; NONHUMAN; PERFORMANCE; PRIORITY JOURNAL; RAT; REINFORCEMENT; RESPONSE TIME;

ANIMALS; CHOICE BEHAVIOR; COCAINE; CONDITIONING, OPERANT; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; HEROIN; MALE; NARCOTICS; RATS; RATS, SPRAGUE-DAWLEY; REINFORCEMENT SCHEDULE; REWARD; SELF ADMINISTRATION;

EID: 12344298372     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1300560     Document Type: Article

References (92)

1. Arnold JM, Roberts DCS (1997). A critique of fixed and progressive ratio schedules used to examine the neural substrates of drug reinforcement. Pharmacol Biochem Behav 57: 441-447.
2. Beswick T, Best D, Rees S, Coomber R, Gossop M, Strang J (2001). Multiple drug use: patterns and practices of heroin and crack use in a population of opiate addicts in treatment. Drug Alcohol Rev 20: 201-204.
3. Bickel WK, Marsch LA, Carroll ME (2000). Deconstructing relative reinforcing efficacy and situating the measures of pharmacological reinforcement with behavioral economics: a theoretical proposal. Psychopharmacology (Berl) 153: 44-56.
4. Bilsky EJ, Montegut MJ, Delong CL, Reid LD (1992). Opioidergic modulation of cocaine conditioned place preferences. Life Sci 50: L85-L90.
5. Brown EE, Finlay JM, Wong JT, Damsma G, Fibiger HC (1991). Behavioral and neurochemical interactions between cocaine and buprenorphine: implications for the pharmacotherapy of cocaine abuse. J Pharmacol Exp Ther 256: 119-126.
6. Camacho LM, Bartholomew NG, Joe GW, Simpson DD (1997). Maintenance of HIV risk reduction among injection opioid users: a 12 month posttreatment follow-up. Drug Alcohol Depend 47: 11-18.
7. Carroll ME, Carmona GN, May SA, Buzalsky S, Larson C (1992). Buprenorphine's effects on self-administration of smoked cocaine base and orally delivered phencyclidine, ethanol and saccharin in rhesus monkeys. J Pharm exp Ther 261: 26-37.
8. Carroll ME, Lac ST (1992). Effects of buprenorphine on self-administration of cocaine and a nondrug reinforcer in rats. Psychopharmacology 106: 439-446.
9. Colon HM, Robles RR, Deren S, Sahai H, Finlinson HA, Andia J et al (2001). Between-city variation in frequency of injection among Puerto Rican injection drug users: East Harlem, New York, and Bayamon, Puerto Rico. J Acquir Immune Defic Syndrome 27: 405-413.
10. Cotton-Oldenburg NU, Carr P, DeBoer JM, Collison EK, Novotny G (2001). Impact of pharmacy-based syringe access on injection practices among injecting drug users in Minnesota, 1998 to 1999. J Acquir Immune Defic Syndrome 27: 183-192.
11. Darke S, Hall W (1995). Levels and correlates of polydrug use among heroin users and regular amphetamine users. Drug Alcohol Depend 39: 231-235.
12. DAWN database Drug Abuse Warning Network (DAWN) Drug Reference Vocabulary. Available online at: http://dawninfo.samhsa.gov/drug_vocab/.
13. Depoortere RY, Li DH, Lane JD, Emmett-Oglesby MW (1993). Parameters of self-administration of cocaine in rats under a progressive-ratio schedule. Pharmacol Biochem Behav 45: 539-548.
14. Downey KK, Helmus TC, Schuster CR (2000). Contingency management for accurate predictions of urinalysis test results and lack of correspondence with self-reported drug use among polydrug abusers. Psychol Addict Behav 14: 69-72 (JID-8802734).
15. Dunteman GH, Condelli WS, Fairbank JA (1992). Predicting cocaine use among methadone patients: analysis of findings from a national study. Hosp Community Psychiatry 43: 608-611.
16. Duvauchelle CL, Sapoznik T, Kornetsky C (1998). The synergistic effects of combining cocaine and heroin ('speedball') using a progressive-ratio schedule of drug reinforcement. Pharmacol Biochem Behav 61: 297-302.
17. Ellinwood Jr EH, Eibergen RD, Kilbey MM (1976). Stimulants: interaction with clinically relevant drugs. Ann NY Acad Sci 281: 393-408.
18. Foltin RW, Fischman MW (1992). The cardiovascular and subjective effects of intravenous cocaine and morphine combinations in humans. J Pharmacol Exp Ther 261: 623-632.
19. Garfein RS, Doherty MC, Monterroso ER, Thomas DL, Nelson KE, Vlahov D (1998). Prevalence and incidence of hepatitis C virus infection among young adult injection drug users. J Acquir Immune Defic Syndrome Hum Retrovirol 18(Suppl 1): S11-S19.
20. Garfein RS, Monterroso ER, Tong TC, Vlahov D, Des J, Selwyn P et al (2004). Comparison of HIV infection risk behaviors among injection drug users from east and west coast US cities. J Urban Health 81: 260-267.
21. Gleghorn AA, Marx R, Vittinghoff E, Katz MH (1998). Association between drug use patterns and HIV risks among homeless, runaway, and street youth in northern California. Drug Alcohol Depend 51: 219-227.
22. Grella CE, Anglin MD, Wugalter SE (1997). Patterns and predictors of cocaine and crack use by clients in standard and enhanced methadone maintenance treatment. Am J Drug Alcohol Abuse 23: 15-42.
23. Griffiths RR, Findley JD, Brady JV, Gutcher K, Robinson WW (1975). Comparison of progressive-ratio performance maintained by cocaine, methylphenidate and secobarbitol. Psychopharmacology 43: 81-83.
24. Hartel DM, Schoenbaum EE, Selwyn PA, Kline J, Davenny K, Klein RS et al (1995). Heroin use during methadone maintenance treatment: the importance of methadone dose and cocaine use. Am J Public Health 85: 83-88.
25. Hasin DS, Grant BF, Endicott J, Harford TC (1988). Cocaine and heroin dependence compared in poly-drug abusers. Am J Public Health 78: 567-569.
26. Hemby SE, Smith JE, Dworkin SI (1996). The effects of eticlopride and naltrexone on responding maintained by food, cocaine, heroin and cocaine/heroin combinations in rats. J Pharmacol Exp Ther 277: 1247-1258 (JID-0376362).
27. Hubner CB, Koob GF (1990). The ventral pallidum plays a role in mediating cocaine and heroin self-administration in the rat. Brain Res 508: 20-29.
28. Hubner CB, Moreton JE (1991). Effects of selective D1 and D2 dopamine antagonists on cocaine self-administration in the rat. Psychopharmacology (Berl) 105: 151-156.
29. Irwin KL, Edlin BR, Faruque S, McCoy HV, Word C, Serrano Y et al (1996). Crack cocaine smokers who turn to drug injection: characteristics, factors associated with injection, and implications for HIV transmission. The Multicenter Crack Cocaine and HIV Infection Study Team. Drug Alcohol Depend 42: 85-92.
30. Joe GW, Simpson DD (1995). HIV risks, gender, and cocaine use among opiate users. Drug Alcohol Depend 37: 23-28.
31. Johanson C-E, Schuster CR (1975). A choice procedure for drug reinforcers: cocaine and methylphenidate in the rhesus monkey. J Pharm Exp Ther 193: 676-688.
32. Kantak KM, Riberdy A, Spealman RD (1999). Cocaine-opioid interactions in groups of rats trained to discriminate different doses of cocaine. Psychopharmacology (Berl) 147: 257-265.
33. Katz JL (1990). Models of relative reinforcing efficacy of drugs and their predictive utility. Behav Pharmacol 1: 283-301.
34. Koob GF, Le HT, Creese I (1987). The D1 dopamine receptor anatagonist SCH 23390 increases cocaine self-administration in the rat. Neurosci Lett 79: 315-320.
35. Kosten TR, Gawin FH, Rounsaville BJ, Kleber HD (1986). Cocaine abuse among opioid addicts: demographic and diagnostic factors in treatment. Am J Drug Alcohol Abuse 12: 1-16.
36. Kosten TR, Rounsaville BJ, Kleber HD (1987). A 2.5-year follow-up of cocaine use among treated opioid addicts. Have our treatments helped? Arch Gen Psychiatry 44: 281-284.
37. Kosten TR, Rounsaville BJ, Kleber HD (1988). Antecedents and consequences of cocaine abuse among opioid addicts. A 2.5-year follow-up. J Nerv Ment Dis 176: 176-181.
38. Kral AH, Bluthenthal RN, Booth RE, Watters JK (1998). HIV seroprevalence among street-recruited injection drug and crack cocaine users in 16 US municipalities. Am J Public Health 88: 108-113.
39. Lamas X, Negus SS, Gatch MB, Mello NK (1998). Effects of heroin/cocaine combinations in rats trained to discriminate heroin or cocaine from saline. Pharmacol Biochem Behav 60: 357-364.
40. Leri F, Bruneau J, Stewart J (2003a). Understanding polydrug use: review of heroin and cocaine co-use. Addiction 98: 7-22 (JID-9304118).
41. Leri F, Flores J, Rajabi H, Stewart J (2003b). Effects of cocaine in rats exposed to heroin. Neuropsychopharmacology 28: 2102-2116.
42. Leri F, Stewart J (2001). Simultaneous self-administration of heroin and cocaine in a rodent model of poly-drug use. Presented at the 6th Annual Meeting of the Center for Studies in Behavioral Neurobiology Montreal, Quebec.
43. Leri F, Stewart J, Tremblay A, Bruneau J (2004). Heroin and cocaine co-use in a group of injection drug users in Montreal. J Psychiatry Neurosci 29: 40-47.
44. Lett BT (1989). Repeated exposures intensify rather than diminish the rewarding effects of amphetamine, morphine, and cocaine. Psychopharmacology (Berl) 98: 357-362.
45. Lile JA, Morgan D, Birmingham AM, Wang Z, Woolverton WL, Davies HM et al (2002). The reinforcing efficacy of the dopamine reuptake inhibitor 2beta-propanoyl-3beta-(4-tolyl)-tropane (PTT) as measured by a progressive-ratio schedule and a choice procedure in rhesus monkeys. J Pharmacol Exp Ther 303: 640-648.
46. Loh EA, Fitch TE, Vickers GJ, Roberts DCS (1992). Clozapine increases breaking points on a progressive-ratio schedule reinforced by intravenous cocaine. Pharmacol Biochem Behav 42: 559-562.
47. Loh EA, Roberts DCS (1990). Break-points on a progressive ratio schedule reinforced by intravenous cocaine increase following depletion of forebrain serotonin. Psychopharmacology 101: 262-266.
48. Magura S, Kang SY, Nwakeze PC, Demsky S (1998). Temporal patterns of heroin and cocaine use among methadone patients. Subst Use Misuse 33: 2441-2467.
49. Manzardo AM, Del Rio JA, Stein L, Belluzzi JD (2001). Rats choose cocaine over dopamine agonists in a two-lever self-administration preference test. Pharmacol Biochem Behav 70: 257-265.
50. Manzardo AM, Stein L, Belluzzi JD (2002). Rats prefer cocaine over nicotine in a two-lever self-administration choice test. Brain Res 924: 10-19.
51. McGregor A, Roberts DCS (1993). Dopaminergic antagonism within the nucleus accumbens or the amygdala produces differential effects on intravenous cocaine self-administration under fixed and progressive ratio schedules of reinforcement. Brain Res 624: 245-252.
52. Meisch RA, Stewart RB (1995). Relative reinforcing effects of different doses of orally delivered cocaine. Drug Alcohol Depend 37: 141-147.
53. Meisch RA, Stewart RB, Wang NS (1996). Orally delivered methadone as a reinforcer for rhesus monkeys: the relationship between drug concentration and choice. Pharmacol Biochem Behav 54: 547-554.
54. Mello NK, Lukas SE, Bree MP, Mendelson JH (1988). Progressive ratio performance maintained by buprenorphine, heroin and methadone in Macaque monkeys. Drug Alcohol Depend 21: 81-98.
55. Mello NK, Lukas SE, Kamien JB, Mendelson JH, Drieze J, Cone EJ (1992). The effects of chronic buprenorphine treatment on cocaine and food self-administration by rhesus monkeys. J Pharm Exp Ther 260: 1185-1193.
56. Mello NK, Mendelson JH, Bree MP, Lukas SE (1989). Buprenorphine suppresses cocaine self-administration by rhesus monkeys. Science 245: 859-861.
57. Mello NK, Mendelson JH, Bree MP, Lukas SE (1990). Buprenorphine and naltrexone effects on cocaine self-administration by rhesus monkeys. J Pharm Exp Ther 254: 926-939.
58. Mello NK, Negus SS (1998). The effects of buprenorphine on self-administration of cocaine and heroin 'speedball' combinations and heroin alone by rhesus monkeys. J Pharmacol Exp Ther 285: 444-456.
59. Mello NK, Negus SS, Lukas SE, Mendelson JH, Sholar JW, Drieze J (1995). A primate model of polydrug abuse: cocaine and heroin combinations. J Pharmacol Exp Ther 274: 1325-1337 (JID-0376362).
60. Miller CL, Johnston C, Spittal PM, Li K, Laliberte N, Montaner JS et al (2002). Opportunities for prevention: hepatitis C prevalence and incidence in a cohort of young injection drug users. Hepatology 36: 737-742.
61. Miller CL, Wood E, Spittal PM, Li K, Prankish JC, Braitstein P et al (2004). The future face of coinfection: prevalence and incidence of HIV and hepatitis C virus coinfection among young injection drug users. J Acquir Immune Defic Syndrome 36: 743-749.
62. Negus SS (2003). Rapid assessment of choice between cocaine and food in rhesus monkeys: effects of environmental manipulations and treatment with D-amphetamine and flupenthixol. Neuropsychopharmacology 28: 919-931.
63. Negus SS, Gatch MB, Mello NK (1998). Discriminative stimulus effects of a cocaine/heroin 'speedball' combination in rhesus monkeys. J Pharmacol Exp Ther 285: 1123-1136 (JID-0376362).
64. Negus SS, Mello NK (2002). Effects of mu-opioid agonists on cocaine- and food-maintained responding and cocaine discrimination in rhesus monkeys: role of mu-agonist efficacy. J Pharmacol Exp Ther 300: 1111-1121.
65. NFLIS (2003). National forensic laboratory information system midyear report. available online at: http://www.deadiversion.usdoj.gov/nflis/ 2003midyear.pdf.2003.
66. NIDA (2002). National institute on drug abuse, epidemiologic trends in drug abuse: advanced report. available online at: http://www.drugabuse.gov/pdf/ cewg/advreport603.pdf.2002.
67. Ochoa KC, Hahn JA, Seal KH, Moss AR (2001). Overdosing among young injection drug users in San Francisco. Addict Behav 26: 453-460.
68. Perez de los CJ, Trujols J, Ribalta E, Casas M (1997). Cocaine use immediately prior to entry in an inpatient heroin detoxification unit as a predictor of discharges against medical advice. Am J Drug Alcohol Abuse 23: 267-279.
69. Ranaldi R, Munn E (1998). Polydrug self-administration in rats: cocaine-heroin is more rewarding than cocaine-alone. Neuroreport 9: 2463-2466 (JID-9100935).
70. Richardson NR, Roberts DCS (1996). Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy. J Neurosci Methods 66: 1-11.
71. Richardson NR, Smith AM, Roberts DCS (1994). A single injection of either flupenthixol decanoate or haloperidol decanoate produces long-term changes in cocaine self-administration in rats. Drug Alcohol Depend 36: 23-25.
72. Roberts DCS, Bennett SAL (1993). Heroin self-administration in rats under a progressive ratio schedule of reinforcement. Psychopharmacology 111: 215-218.
73. Roberts DCS, Bennett SAL, Vickers GJ (1989). The estrous cycle affects cocaine self-administration on a progressive ratio schedule in rats. Psychopharmacology 98: 408-411.
74. Roberts DCS, Goeders NE (1989). Drug self-administration: experimental methods and determinants. In: Boulton AA, Baker GB, Greenshaw AJ (eds). Neuromethods. Humana Press: Clifton, NJ, pp 349-398.
75. Rowlett JK, Wucox KM, Woolverton WL (1998). Self-administration of cocaine-heroin combinations by rhesus monkeys: antagonism by naltrexone. J Pharmacol Exp Ther 286: 61-69 (JID-0376362).
76. Rowlett JK, Woolverton WL (1997). Self-administration of cocaine and heroin combinations by rhesus monkeys responding under a progressive-ratio schedule. Psychopharmacology (Berl) 133: 363-371 (JID-7608025).
77. Saxon AJ, Wells EA, Fleming C, Jackson TR, Calsyn DA (1996). Pre-treatment characteristics, program philosophy and level of ancillary services as predictors of methadone maintenance treatment outcome. Addiction 91: 1197-1209.
78. Schutz CG, Vlahov D, Anthony JC, Graham NM (1994). Comparison of self-reported injection frequencies for past 30 days and 6 months among intravenous drug users. J Clin Epidemiol 47: 191-195.
79. Shahan TA, Bickel WK, Madden GJ, Badger GJ (1999). Comparing the reinforcing efficacy of nicotine containing and de-nicotinized cigarettes: a behavioral economic analysis. Psychopharmacology (Berl) 147: 210-216.
80. Solinas M, Panlilio LV, Goldberg SR (2004). Exposure to delta-9-tetrahydrocannabinol (THC) increases subsequent heroin taking but not heroin's reinforcing efficacy: a self-administration study in rats. Neuropsychopharmacology 29: 1301-1311.
81. Spealman RD, Bergman J (1992). Modulation of the discriminative stimulus effects of cocaine by mu and kappa opioids. J Pharmacol Exp Ther 261: 607-615.
82. Stine SM, Kosten TR (1993). Cocaine precipitation of patient-identified opiate withdrawal. Am J Addict 2: 255-258.
83. Stretch R (1977). Discrete-trial control of cocaine self-injection behaviour in squirrel monkeys: effects of morphine, naloxone, and chlorpromazine. Can J Physiol Pharmacol 55: 778-790.
84. Suzuki T, Mori T, Tsuji M, Misawa M, Nagase H (1997). The role of delta-opioid receptors in the discriminative stimulus properties of a low dose of methamphetamine. Eur J Pharmacol 331: 1-8.
85. Thorpe LE, Quellet LJ, Levy JR, Williams IT, Monterroso ER (2000). Hepatitis C virus infection: prevalence, risk factors, and prevention opportunities among young injection drug users in Chicago, 1997-1999. J Infect Dis 182: 1588-1594.
86. Van Ameijden EJ, Langendam MW, Notenboom J, Coutinho RA (1999). Continuing injecting risk behaviour: results from the Amsterdam Cohort Study of drug users. Addiction 94: 1051-1061.
87. Walsh SL, Sullivan JT, Preston KL, Garner JE, Bigelow GE (1996). Effects of naltrexone on response to intravenous cocaine, hydromorphone and their combination in humans. J Pharmacol Exp Ther 279: 524-538.
88. Wang NS, Brown VL, Grabowski J, Meisch RA (2001). Reinforcement by orally delivered methadone, cocaine, and methadone-cocaine combinations in rhesus monkeys: are the combinations better reinforcers? Psychopharmacology (Berl) 156: 63-72 (JID-7608025).
89. Ward SJ, Martin TJ, Roberts DC (2003). Beta-funaltrexamine affects cocaine self-administration in rats responding on a progressive ratio schedule of reinforcement. Pharmacol Biochem Behav 75: 301-307.
90. Wilson MC, Schuster CR (1973). Cholinergic influence on intravenous cocaine self-administration by rhesus monkeys. Pharmacol Biochem Behav 1: 643-649.
91. Winger G, Skjoldager P, Woods JH (1992). Effects of buprenorphine and other opioid agonists and antagonists on alfentaniland cocaine-reinforced responding in rhesus monkeys. J Pharm Exp Ther 261: 311-317.
92. Woolverton WL, Johanson C-E (1984). Preference in rhesus monkeys given a choice between cocaine and D,L-cathinone. J Exp Anal Behav 41: 35-43.